NYU, UCLA get $2.4M grant to study cannabinoids for cancer pain
The New York University (NYU) Bluestone Center for Clinical Research and the University of California, Los Angeles (UCLA) have received a five-year, $2.4 million grant
The New York University (NYU) Bluestone Center for Clinical Research and the University of California, Los Angeles (UCLA) have received a five-year, $2.4 million grant
What if you never had to administer anesthesia through a needle again? A recent study evaluated the possibility of using an electric current instead of
Key markers from electroencephalography (EEG) may help track the depth of anesthesia patients’ experience with propofol, according to a new study. The researchers hope their
Wand Dental announced that it has received an initial stocking order from Henry Schein for the Wand STA computer-assisted anesthesia system. The stocking order enables
After surgery, many children use less than half of their prescribed opioid medication, according to a recent study. This finding is particularly worrying because many
The ADA has released its Practical Guide to Substance Use Disorders and Safe Prescribing. The guide covers topics such as the following: Drug diversion Understanding
While dentists are prescribing fewer opioids than in past years, the death rate from drug overdose in the U.S. more than doubled from 6 to
The U.S. Patent and Trademark Office has awarded Solace Lifesciences a patent for NuCalm, a technology designed to relieve stress in dental patients. NuCalm involves
In part one of this series, two dental professionals addressed how to help prevent substance abuse through education, ideal pain management prescriptions, and screenings. This
About 1 in 4 people abuse drugs and alcohol, according to a presentation at the recent California Dental Association’s CDA Presents 2015 meeting in San
The Foundation for Facial Recovery has officially launched after receiving tax-exempt status from the Internal Revenue Service (IRS). The foundation will provide educational programs and
Pennsylvania’s Department of Drug and Alcohol Programs (DDAP) and Department of Health have released guidelines for prescribing opioids for acute or chronic head and orofacial